Healthcare Deal Sourcing: How to Evaluate GenAI Impact on Value
Sourcescrub considers how generative AI will impact company value in the healthcare sector with important considerations for investors
Healthcare
Navigating the Turbulent Waters of Healthcare Mergers and Acquisitions
While labor shortages and rising bankruptcies are weighing on the healthcare sector, investors still see M&A opportunities in select niches
Healthcare Report 2023
In the first of our series of sector-focused digital reports, Middle Market Growth spotlights healthcare, highlighting trends shaping M&A opportunities within the sector.
Cell Therapy: A New M&A Frontier
Cellares co-founder and CEO Fabian Gerlinghaus shares his unique approach to developing successful cell therapies
AI Creates a Flurry of M&A Activity in Healthcare RCM and HCIT
From PE investors to strategic acquirers, AI is fueling M&A activity within RCM and HCIT
Taking the Pulse of Healthcare M&A with Twin Brook’s Tim Wentink
This episode is brought to you by Twin Brook Capital Partners, a leading direct lending finance company focused on providing cash-flow based financing solutions for the middle market private equity community
Manufacturing M&A Success Among Gene and Cell Therapy Innovators
Investors look beyond product success to overcome the supply chain challenges of lifesaving therapy development
PE Weekly: Dealmakers Turn to Healthcare in a Slow Week for M&A
Middle-market dealmakers close out May with a slow week for M&A, but healthcare finishes the month strong
Thematic Investing Brings PE to the Clinical Trials Market
COVID-19 shone a light on a fragmented market. Now private equity firms are building platforms of clinical site businesses with an eye toward improving diversity.
Navigating Human Capital Challenges in Healthcare M&A
Insperity and Medaxion discuss their collaboration on seamless healthcare rollups